image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

S4 Capital - Shares surge towards £7

August 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SFOR
  • Price:
  • 647p
The shares hit new highs after S4 said trading accelerated strongly with revenues up 90% in the first four months of 2021. compared with 71% for Q1. Gross profit rose 84% and 71% over the same periods. Early indications are that May will be similar to April while the pipeline for June continues to be robust. Tech clients (over 50% revenues) are still outspending other sectors such as FMCG and retail. As a result, management, which had previously raised organic gross profit guidance from +25% to +30% for 2021, have now raised it again to +35%. S4 also said it is in the process of raising a term loan of over US$350m and Jefferies says this, together with existing cash and its preferred 50:50 cash equity mer ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X